Orexigen defeats Actavis in weight loss pill battle


US pharmaceutical company Orexigen Therapeutics has won a patent infringement case against Actavis Laboratories after suing the company over weight loss pill Contrave (naltrexone HCl/bupropion HCl extended release).

Orexigen; Actavis; weight loss; patent; patent infringement; ANDA; US District Court for the District of Delaware; Contrave